Trials / Completed
CompletedNCT03560804
Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two Drugs
Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect. Comparison Between an ATII Receptor Antagonist and a Diuretic.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- AHEPA University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The principal aim of the study is to determine whether the hemodynamic parameters measured with the two methods -impedance cardiography and applanation tonometry- can be predictive of the antihypertensive effect of two different classes of drugs, ATII antagonists and diuretics. The drugs that will be used in the study are olmesartan and chlorthalidone and the duration of the study is 12 months. The other basic aim of the study is to determine whether there is a difference (\>6mmHg) between the two drugs regarding the reduction of the mean 24hour blood pressure and the effect of them on the hemodynamic parameters. The hemodynamic parameters that will be measured by applanation tonometry are augmentation index, central blood pressure and pulse wave velocity. The hemodynamic parameters that will be measured by impedance cardiography are cardiac index, thoracic fluid content index, systemic vascular resistance index and others.
Detailed description
The principal aim of the study is to determine whether the hemodynamic parameters measured with the two methods -impedance cardiography and applanation tonometry- can be predictive of the antihypertensive effect of two different classes of drugs, ATII antagonists and diuretics. The drugs that will be used in the study are olmesartan and chlorthalidone and the duration of the study is 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olmesartan | Administration of olmesartan at starting dose and titrating in order to reach the target blood pressure. |
| DRUG | Chlorthalidone | Administration of chlorthalidone at starting dose and titrating in order to reach the target blood pressure. |
Timeline
- Start date
- 2014-11-10
- Primary completion
- 2017-09-15
- Completion
- 2017-09-15
- First posted
- 2018-06-18
- Last updated
- 2018-06-18
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT03560804. Inclusion in this directory is not an endorsement.